AstraZeneca
Pharma lobbies DC for off-label rights
Submitted by MichaelVail on Fri, 04/18/2008 - 6:04pm.
Drugmakers are descending on Washington to protect their freedom to advertise meds directly to consumers and push for looser government restrictions on off-label promotion, The Wall Street Journal writes.

Bookmark this site
Bookmark this page
Make Us your homepage



